Jefferies Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-160,100
Closed -$15.9M 3282
2019
Q3
$15.9M Sell
160,100
-25,800
-14% -$2.45M 0.12% 112
2019
Q2
$17.2M Sell
185,900
-1,221,000
-87% -$116M 0.13% 119
2019
Q1
$133M Buy
1,406,900
+1,161,500
+473% +$102M 1.09% 14
2018
Q4
$15.7M Sell
245,400
-181,500
-43% -$13.4M 0.13% 120
2018
Q3
$38.2M Buy
426,900
+21,100
+5% +$1.86M 0.25% 52
2018
Q2
$32.2M Buy
405,800
+392,200
+2,884% +$32.6M 0.18% 73
2018
Q1
$1.21M Sell
13,600
-79,000
-85% -$7.58M 0.01% 1113
2017
Q4
$9.66M Buy
92,600
+83,600
+929% +$9.43M 0.05% 316
2017
Q3
$1.31M Sell
9,000
-900
-9% -$123K 0.01% 1157
2017
Q2
$1.29M Sell
9,900
-14,900
-60% -$1.83M 0.01% 1171
2017
Q1
$3.09M Sell
24,800
-62,000
-71% -$7.42M 0.02% 717
2016
Q4
$10M Buy
86,800
+60,300
+228% +$6.72M 0.06% 342
2016
Q3
$2.77M Sell
26,500
-53,700
-67% -$5.81M 0.01% 784
2016
Q2
$7.91M Sell
80,200
-45,600
-36% -$4.72M 0.04% 347
2016
Q1
$12.6M Sell
125,800
-195,300
-61% -$20.1M 0.07% 209
2015
Q4
$38.5M Buy
321,100
+222,800
+227% +$25.8M 0.22% 77
2015
Q3
$10.6M Buy
98,300
+31,500
+47% +$3.91M 0.06% 249
2015
Q2
$7.73M Buy
+66,800
New +$7.64M 0.04% 366
2015
Q1
Sell
-22,500
Closed -$2.52M 2676
2014
Q4
$2.52M Sell
22,500
-50,900
-69% -$5.37M 0.01% 636
2014
Q3
$6.96M Buy
+73,400
New +$6.62M 0.05% 329
2013
Q4
Sell
-34,000
Closed -$2.62M 2515
2013
Q3
$2.62M Sell
34,000
-83,800
-71% -$5.87M 0.03% 510
2013
Q2
$6.89M Buy
+117,800
New +$7.09M 0.07% 193

Other funds holding CELG

Jefferies Group's CELG Position: Q4 2019 in Review

Jefferies Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 577,965 shares — an estimated $57.4M sold.

Jefferies Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $57.4M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Jefferies Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Jefferies Group sold 577,965 Celgene Corp shares in Q4 2019, an estimated $57.4M.
  • Jefferies Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Jefferies Group's Celgene Corp position peaked at $57.4M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.